Is GALT or QTTB more profitable?

QTTB runs the higher net margin — GALT at 0.00% versus QTTB at 62.87%.

How have GALT and QTTB total returns compared?

Over the past 5 years, GALT delivered 0.60% and QTTB delivered -41.51% annualized total return. Past performance doesn't predict future results.

Galectin Therapeutics Inc. (GALT) vs Q32 Bio Inc. (QTTB)

A side-by-side comparison of Galectin Therapeutics Inc. and Q32 Bio Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

GALT

Galectin Therapeutics Inc.

$242M

$3.68HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

QTTB

Q32 Bio Inc.

$240M

$8.06HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

Total return — GALT vs QTTB

growth of $100 · dividends reinvested · last 9y

GALT -19.4% (-2.4%/yr)QTTB -97.5% (-33.7%/yr)GALT compounded faster over this window

Log scale — wide-divergence pair

GALT QTTB

GALT vs QTTB: by the numbers

•GALT is the larger company ($242M vs $240M market cap).
•QTTB is profitable (62.87% net margin) while GALT runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	GALT	QTTB
P/E ratio	N/A	2.89
P/S ratio	N/A	4.46
P/B ratio	N/A	2.27
EV / EBITDA	N/A	6.34

Profitability

Metric	GALT	QTTB
Gross margin	0.00%	99.84%
Operating margin	0.00%	31.45%
Net margin	0.00%	62.87%
ROE	N/A	31.90%
ROIC	-1718.59%	19.43%

Growth (annualized)

Metric	GALT	QTTB
Revenue CAGR (5Y)	N/A	10.22%
Total return CAGR (5Y)	0.60%	-41.51%

Frequently asked

Is GALT or QTTB more profitable?: QTTB runs the higher net margin — GALT at 0.00% versus QTTB at 62.87%.
How have GALT and QTTB total returns compared?: Over the past 5 years, GALT delivered 0.60% and QTTB delivered -41.51% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GALT analysis Full QTTB analysis Interactive comparison tool

Dig into the metrics

Q32 Bio P/E ratio Galectin Therapeutics ROE Q32 Bio ROE Galectin Therapeutics operating margin Q32 Bio operating margin Galectin Therapeutics revenue growth Q32 Bio revenue growth Galectin Therapeutics free cash flow Q32 Bio free cash flow

Galectin Therapeutics & Q32 Bio appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.